Basic Materials · Chemicals · NYSE · United States
$32.61+2.51%
Market cap $23.6BNext earnings 2026-10-22Updated Oct 23, 2026
Our verdict
Trades 45% below our fair value
Price
$32.61
Model fair valueConfidence: low
about $59.62
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionDow Inc. Common Stock (DOW)
Fair value (2 models)
Not available
ACCE price target
$33.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST; previously $27.00 since 25 Sept 2026, 00:00 CEST.
Price used: $32.61 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
45
out of 100
Analysts
25% buy
20 covering
1-year return
+33.0%
Dividend yield
4.40%
Dow Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Dow Inc. makes polyethylene, polyurethanes, silicones and other base and specialty plastics, mostly sold to packaging, construction and consumer goods makers, with a large footprint of integrated US Gulf Coast and European production. Its advantage is scale and feedstock integration in commodity petrochemicals, which tends to matter most when the cycle turns, though the current cycle is still weak for the sector. Trailing earnings are negative (ROE of -5.5%), so the valuation case rests on the forward multiple of 16.3x and on a revenue rebound of 19.7%, which would need to show up as margin recovery to be meaningful; the reported 9.8% gross margin and 11.6% operating margin leave little room for error. The stock's near-term fate depends on whether pricing and volumes in polyethylene improve, and on the pace of cost cuts already announced. At a $20.3B market cap with no index membership, the name is a cyclical turnaround candidate rather than a quality compounder, and the score of 45/100 reflects that. Worth a deeper look only if the team has a differentiated view on the petrochemical cycle.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Earnings collapse with negative margins
EPS down 73.3% YoY; net margin -3.1% and ROE -5.2%. Company is unprofitable despite revenue growth, signalling operational distress or one-time charges.
high
Elevated leverage amid earnings weakness
Debt/Equity 1.12 is material. Combined with negative earnings and -11.1% five-year revenue CAGR, refinancing risk rises if conditions deteriorate further.
moderate
Quality score collapse signals deterioration
ACCE Quality subscore only 31/100. Recent +16 point score jump driven by valuation and growth, not operational improvement; underlying fundamentals remain weak.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue surged 19.7% year over year, and earnings beat expectations by 15.2%, signaling strong near-term demand.
The stock trades at 16.5x forward earnings with a 4.9% dividend yield, offering income at a reasonable valuation.
Analysts see 18.3% upside to their mean price target of $33.63, with 26% rating the stock a buy.
Why it could disappoint
Five year revenue has fallen 11.1% annually, and the company is unprofitable with negative 3.1% net margins.
Return on equity of negative 5.5% and return on invested capital of negative 6.5% show the business destroys shareholder value.
Free cash flow yield of 1.2% is meager, and debt to equity of 1.12 leaves little room to protect a 4.9% dividend.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where DOW's valuation models land
Price
$32.61
Model fair valueConfidence: low
about $59.62
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores